Pluto Bioinformatics

GSE107423: Next generation sequencing facilitates quantitative analysis of murine high-grade glibablastoma Transcriptomes after VEGF-A blockade In Vivo.

Bulk RNA sequencing

The goals of this study are to compare immunogenic profiling of tumor tissue from GL261 burden mice were treated with different dose VEGF-A antibody from Day10 after tumor implantation to the endpoint. The treatment doses are 0ug, 50ug, 100ug and 200ug. SOURCE: Jianping Huang (Jianping.Huang@neurosurgery.ufl.edu) - Dr. Jianping Huang UF